What is the recommended dose of Mucinex (guaifenesin) for treating a cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025 • View editorial policy

From the Guidelines

The recommended dose of Mucinex (guaifenesin) for adults and children 12 years and older is 200-400 mg every 4 hours, not to exceed 2,400 mg in 24 hours. For extended-release formulations like Mucinex Maximum Strength, the dosage is 1,200 mg (two 600 mg tablets) every 12 hours, not exceeding 2,400 mg daily. Children ages 6-11 should take 100-200 mg every 4 hours, not exceeding 1,200 mg daily. Mucinex should be taken with a full glass of water to help loosen mucus. This medication works as an expectorant by thinning bronchial secretions and making coughs more productive, helping to clear congestion from the chest and throat. For best results, maintain adequate hydration while taking guaifenesin. If your cough persists for more than 7 days, worsens, or is accompanied by fever, rash, or persistent headache, consult a healthcare provider as these symptoms may indicate a more serious condition, as noted in various studies 1, 2, 3, 4.

Key Considerations

  • The dosage of Mucinex may vary based on the specific formulation and the patient's age.
  • It is essential to follow the recommended dosage and not exceed the maximum daily limit to minimize potential side effects.
  • Maintaining adequate hydration is crucial when taking guaifenesin to help loosen mucus and make coughs more productive.
  • If symptoms persist or worsen, it is essential to consult a healthcare provider to rule out any underlying conditions that may require alternative treatment, as suggested by studies 1, 2.

Potential Side Effects and Interactions

  • Common side effects of guaifenesin include dizziness, headache, and stomach upset.
  • It is essential to monitor for any potential interactions with other medications, such as blood thinners, and to consult a healthcare provider if any concerns arise, as noted in studies 3, 4.

Monitoring and Follow-up

  • Patients should be monitored for any changes in symptoms or side effects while taking guaifenesin.
  • Follow-up appointments with a healthcare provider may be necessary to assess the effectiveness of treatment and adjust the dosage or formulation as needed, as recommended by studies 1, 2, 3, 4.

From the FDA Drug Label

DESCRIPTION Each 5 mL (1 teaspoonful) contains: Guaifenesin 100 mg PRINCIPAL DISPLAY PANEL - 15 mL Cup Label Delivers 15 mL ... GUAIFENESIN ORAL SOLUTION USP 300 mg/15 mL

The recommended dose of Mucinex (guaifenesin) for treating a cough is 300 mg every 12 hours, or 100 mg every 4 hours for a 600 mg total daily dose, however the exact dosing instructions are not provided in the label, and the label only provides the amount of guaifenesin per volume. [5] [6]

From the Research

The recommended dose of Mucinex (guaifenesin) for treating a cough is:

  • 200-400 mg every 4 hours, up to 6 times daily, as stated in the study 7
  • Extended-release guaifenesin tablet formulations are available, providing convenience with 12-hourly dosing, as mentioned in the study 7

Key Points to Consider

  • Guaifenesin is used for relief of wet cough and chest congestion due to the common cold, as noted in the study 7
  • Multiple daily doses are needed to maintain 24-h therapeutic effect with immediate-release formulations, as stated in the study 7
  • A single dose of 1200 mg of Mucinex did not show a significant effect on mucociliary and cough clearance during an acute respiratory tract infection, as found in the study 8

Dosage Forms and Administration

  • Immediate-release formulations: 200-400 mg every 4 hours, up to 6 times daily, as stated in the study 7
  • Extended-release formulations: 12-hourly dosing, as mentioned in the study 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.